2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
cessive primary microcephaly). So far four genes have been identified:<br />
MCPH1, encoding Microcephalin; MCPH3, encoding CDK5RAP2;<br />
MCPH5, encoding ASPM, and MCPH6, encoding CENPJ . MCPH5<br />
and MCPH1 are the most common loci based on MCPH heterogeneity<br />
studies in Pakistani and Indian populations . The objective <strong>of</strong> this study<br />
was to investigate prevalence <strong>of</strong> ARMR associated with microcephaly<br />
in Iranian families from northeast & southeast <strong>of</strong> Iran . A total <strong>of</strong> 20 consanguineous<br />
families with two or more affected individuals with ARMR<br />
inheritance pattern have been collected after obtaining consent form .<br />
Clinical examination and exclusion <strong>of</strong> chromosomal abnormalities <strong>of</strong><br />
the families were completed and followed by homozygosity mapping<br />
using STRs (Short Tandem Repeats) markers for six mentioned MCPH<br />
loci . Sequencing was performed for the linked families . Nine out <strong>of</strong><br />
twenty families were linked to four <strong>of</strong> these loci as follows: Five were<br />
linked to MCPH5 (25%), and MCPH1, MCPH2 were linked to one family<br />
each (5%), and two were linked to MCPH6 (10%) . We have been<br />
able to identify four novel mutations in four families <strong>of</strong> the MCPH5 . According<br />
to our findings MCPH5 seems to be the most prevalent loci in<br />
Iranian families with mental retardation and microcephaly . Sequencing<br />
for the other linked families is currently underway .<br />
P05.123<br />
microRNA expression and post-transcriptional target genes<br />
analysis from one pair <strong>of</strong> monozygotic twins discordant for<br />
trisomy 21: understanding phenotypic variability in Ds patients<br />
C. Borel, S. Deutsch, C. Gehrig, M. Gagnebin, S. E. Antonarakis;<br />
Department <strong>of</strong> Genetic Medicine and Development, University <strong>of</strong> Geneva Medical<br />
School, CH, GENEVA, Switzerland.<br />
The understanding <strong>of</strong> the molecular pathogenesis <strong>of</strong> trisomy 21 (T21)<br />
is remarkably poor since it is not clear how the extra copy <strong>of</strong> HSA21<br />
leads to a wide range <strong>of</strong> phenotypes . We investigated a new class<br />
<strong>of</strong> functional sequences: microRNAs (miRNAs), that act primarily as<br />
post-transcriptional repressors <strong>of</strong> target genes through 3’UTR interactions.<br />
We studied microRNA gene variation on primary fibroblasts and<br />
heart tissue from one pair <strong>of</strong> monozygotic twins discordant for T21 .<br />
Expression was assayed using Taqman qRT-PCR on 365 mature miR-<br />
NAs, 4 <strong>of</strong> which are encoded by HSA21 . Most <strong>of</strong> deregulated microR-<br />
NAs are tissue specific. Around 12% (fibroblasts) and 25% (heart) <strong>of</strong><br />
microRNAs show a statistically significant difference between the T21<br />
and normal twin, with an average up-regulation <strong>of</strong> 1 .6fold and downregulation<br />
<strong>of</strong> 0 .6fold . Expression levels revealed that HSA21-miR-155<br />
and HSA21-miR-99a are up-regulated about 2fold in fibroblasts and<br />
heart tissue, respectively . We have also examined transcripts that are<br />
post-transcriptionally deregulated in T21 and potential target genes<br />
<strong>of</strong> those deregulated microRNAs . To do so, we separated RNA molecules<br />
<strong>of</strong> primary fibroblasts from the same pair <strong>of</strong> twin in a sucrose<br />
gradient according to their association with ribosomes . Pools <strong>of</strong> fractions<br />
corresponding to the heavy ribosomal fraction (translated RNA)<br />
and total RNA were hybridized to a gene expression microarray . We<br />
identified 45 and 63 transcripts with a post-transcriptional up-regulation<br />
and downregulation in the T21 twin, respectively . To complete this<br />
study, we are currently looking for predicted miRNA target genes and<br />
correlated miRNA expression with the expression <strong>of</strong> its target genes .<br />
P05.124<br />
Distinctive patterns <strong>of</strong> miRNA expression in human muscular<br />
disorders<br />
I. Eisenberg1,2 , A. Eran1 , H. G. Lidov1 , P. B. Kang1 , I. S. Kohane1 , L. M. Kunkel1,2<br />
;<br />
1 2 Children’s Hospital Boston, Boston, MA, United States, Howard Hughes Medical<br />
Institute, Boston, MA, United States.<br />
The muscular disorders are a heterogeneous group <strong>of</strong> inherited diseases<br />
characterized by muscle wasting and progressive weakness,<br />
resulting in significant morbidity and disability. Although considerable<br />
progress has been made in the understanding <strong>of</strong> these disorders, the<br />
underlying molecular pathways remain poorly understood . In light <strong>of</strong><br />
their involvement in modulating cellular phenotypes we hypothesized<br />
that miRNAs might be involved in the regulation <strong>of</strong> the pathological<br />
pathways leading to muscle dysfunction . We describe a comprehensive<br />
miRNA expression pr<strong>of</strong>ile aiming to identify new elements involved<br />
in the regulatory networks <strong>of</strong> muscle and the signature pattern <strong>of</strong> 185<br />
miRNAs associated with ten common myopathological conditions in<br />
human. While five miRNAs were found to be consistently dysregulated<br />
in all samples analyzed suggesting that these miRNAs are involved in<br />
a common underlying regulatory pathway among all diseases, other<br />
miRNAs were identified to be dysregulated only in one given disease<br />
and not in any <strong>of</strong> the others thus pointing to their involvement in a<br />
unique regulatory mechanism .<br />
The subsequent identification <strong>of</strong> potential target genes and the unraveling<br />
<strong>of</strong> biological signaling pathways involved in this regulatory<br />
level in these disorders, point to an additional dimension <strong>of</strong> regulation<br />
<strong>of</strong> muscle function mediated by miRNAs . Together with the tight post<br />
transcriptional regulation at the mRNA level identified in Duchenne and<br />
Miyoshi myopathy and specific mRNA:miRNA predicted interactions,<br />
some <strong>of</strong> which are directly involved in compensatory secondary response<br />
functions and others in muscle regeneration, these findings<br />
suggest an important role <strong>of</strong> miRNAs in the pathology <strong>of</strong> muscular<br />
dystrophy .<br />
P05.125<br />
multiple sclerosis Disease and mitochondria<br />
M. Houshmand;<br />
NIGEB, Tehran, Islamic Republic <strong>of</strong> Iran.<br />
Multiple Sclerosis (MS) is a multifocal demyelinating central nervous<br />
system disorder . To assess relationship between mtDNA haplogroups<br />
and MS, we have sequenced the mtDNA HVS-I in 54 MS patients and<br />
100 control subjects . In this study, kinetic analysis <strong>of</strong> mitochondrial<br />
respiratory chain complex I enzyme was performed on intact mitochondria<br />
isolated from fresh skeletal muscle in MS patients (n =10)<br />
and control subjects (n =11) . The frequencies <strong>of</strong> the Asian (M, BM)<br />
and <strong>European</strong> (N, J, K) mtDNA haplogroups in five major regions <strong>of</strong><br />
Iran was investigated . Unexpectedly, the frequencies <strong>of</strong> the Asian haplogroups<br />
M and BM were low in Iran (2 .34% for haplogroup M; 17 .6%<br />
for haplogroup BM and 80 .06% for haplogroup N) .<br />
We have found that haplogroups A and K are significantly more abundant<br />
in MS patients (P=0 .042 for haplogroup A and P=0 .0005 for haplogroup<br />
K). Our findings showed that complex I activities were significantly<br />
reduced ( P=0 .007) in patients compared with control . However,<br />
we could not find deletion in mtDNA <strong>of</strong> patients with MS. Our results<br />
revealed that 15 (75%) out <strong>of</strong> 20 MS patients had point mutations .<br />
This study suggested that point mutation occurred in mtDNA might be<br />
involved in pathogenesis <strong>of</strong> MS . Our data suggest that Iranian tribes<br />
probably played a remarkable role in the formation <strong>of</strong> these ethnic<br />
groups . It gives the indication that the haplogroup J may be older than<br />
6000-10000 years, and probably developed in Iran, and then expanded<br />
to different regions in Europe and Northwest Asia .<br />
P05.126<br />
the coexistence <strong>of</strong> an East-Asian mitochondrial anthropological<br />
marker and the c8270t, A8332c, and A8347c mtDNA mutations<br />
in a Hungarian family with dystonia and juvenile stroke<br />
syndrome<br />
A. Gal 1 , K. Pentelenyi 1 , V. Remenyi 1 , B. Csanyi 2 , G. Tomory 2 , I. Rasko 2 , M. J.<br />
Molnar 1,3 ;<br />
1 Department <strong>of</strong> Neurology, Semmelweis University, Center <strong>of</strong> Molecular Neurology,<br />
Budapest, Hungary, 2 Biological Research Center, Szeged, Hungary, 3 Montreal<br />
Neurological Institute, McGill University, Montreal, QC, Canada.<br />
The high variability <strong>of</strong> the mitochondrial genome contributes to the<br />
phenotype <strong>of</strong> the mtDNA-related disorders . MtDNA mutations have<br />
been associated with a variety <strong>of</strong> clinical manifestations . The 9-bp<br />
deletion between mtDNA 8271-8280 was originally thought to be an<br />
anthropological marker for peoples <strong>of</strong> East-Asian origin .<br />
The proband was investigated for marked dystonic features . The clinical<br />
symptoms started after a long lasting episode <strong>of</strong> fever and elevated<br />
serum ammonia and lactate level . His brother had transient hyperkinesis,<br />
right hemiparesis . Their mother had in her childhood a stroke with<br />
aphasia and right hemiparesis . Presently she has moderate truncal<br />
ataxia, hypoacusis and cognitive dysfunction .<br />
The mtDNA analysis <strong>of</strong> the proband found a 9bp deletion “CCCCCTCA”<br />
in the mtDNA at the position nt8271-8280, and one C8270T substitution<br />
between COII and tRNA Lys genes in the non-coding hypervariable<br />
segment, and two SNPs (A8332G and A8347C) in the tRNA Lys gene .<br />
The C8270T SNP is a pathogenic mutation, the A8332G and A8347C<br />
SNPs are not described in the literature . None <strong>of</strong> the three SNP was<br />
found in our 100 control cases . The affected Hungarian family belongs<br />
to an ancient B mitochondrial haplogroup .